Thermo Fisher Scientific Authorizes $4 Billion of Share Repurchases
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its board of directors has authorized the repurchase of $4 billion of shares of its common stock in the open market or in negotiated transactions. The authorization has no expiration date.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.
Global Blue Group Holding AG (the "Company") has continued to demonstrate a robust recovery, underpinned by the entrenched behaviour of travel and shopping, driving significant EBITDA and cash flow growth. Consequently, net leverage reduced from...
The Edelman Trust Barometer reveals that brand loyalty often begins after the first purchase, which shows that effective branding resonates at the point of sale and...
BlueHalo, the company transforming the future of global defense, and Kraken Technology Group, a maritime technology leader specializing in disruptive high-performance platforms, today announced a strategic partnership to integrate BlueHalo's...
Fulgent Genetics, Inc. ("Fulgent," or the "Company"), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced financial results for its first quarter ended March 31,...
2seventy bio, Inc. will announce its first quarter 2024 financial results on Wednesday, May 8, 2024. A conference call and webcast will be held at 8:00 a.m. ET.
Participants can access the conference call live via webcast which will be available...
FiscalNote Holdings, Inc. ("FiscalNote"), a leading AI-driven enterprise SaaS technology provider of global policy and market intelligence, today announced that members of the senior management team will be participating in the following upcoming...
